Mesoblast Ltd banner

Mesoblast Ltd
NASDAQ:MESO

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
NASDAQ:MESO
Watchlist
Price: 17.04 USD 1.13% Market Closed
Market Cap: $1.9B

Wall Street
Price Targets

MESO Price Targets Summary
Mesoblast Ltd

Wall Street analysts forecast MESO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MESO is 18.46 USD with a low forecast of 17.96 USD and a high forecast of 19.51 USD.

Lowest
Price Target
17.96 USD
5% Upside
Average
Price Target
18.46 USD
8% Upside
Highest
Price Target
19.51 USD
14% Upside
Mesoblast Ltd Competitors:
Price Targets
PTEN
Patterson-UTI Energy Inc
-7% Downside
WOOF
Petco Health and Wellness Company Inc
44% Upside
CIGI
Colliers International Group Inc
14% Upside
ARDX
Ardelyx Inc
120% Upside
LVS
Las Vegas Sands Corp
21% Upside
INO
Inovio Pharmaceuticals Inc
420% Upside
CDNA
CareDx Inc
20% Upside

Revenue
Forecast

-1% / Year
Past Growth
177% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
-1% / Year
Past Growth
177% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

For the last 14 years the compound annual growth rate for Mesoblast Ltd's revenue is -1%. The projected CAGR for the next 3 years is 177%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MESO's stock price target?
Price Target
18.46 USD

According to Wall Street analysts, the average 1-year price target for MESO is 18.46 USD with a low forecast of 17.96 USD and a high forecast of 19.51 USD.

What is Mesoblast Ltd's Revenue forecast?
Projected CAGR
177%

For the last 14 years the compound annual growth rate for Mesoblast Ltd's revenue is -1%. The projected CAGR for the next 3 years is 177%.

Back to Top